30 Day Trial

NuVasive 2Q18 Revenue +8.5% vs. 2Q17

Share:

NuVasive reported 2Q18 revenue of US $281.6MM, +8.5% vs. 2Q17, and 1H18 revenue of $542.1MM, +6.6% vs. 1H17.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.